Roche obtiene marcado CE para su inmunoanalizador cobas smart e
- Roche obtiene el marcado CE para su inmunoanalizador cobas smart e, destinado a ampliar las pruebas diagnósticas en laboratorios pequeños.
- La plataforma prevé ofrecer más de 100 pruebas, con tiempos de reacción de hasta 18 minutos para más del 90%.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270200OMX_____CNEWS_EN_GNW1001279954_en) on October 27, 2026, and is solely responsible for the information contained therein.